Stiolto Respimat Prices, Coupons and Patient Assistance Programs
Stiolto Respimat (olodaterol/tiotropium) is a member of the bronchodilator combinations drug class and is commonly used for COPD, and COPD - Maintenance.
The cost for Stiolto Respimat inhalation aerosol (2.5 mcg-2.5 mcg/inh) is around $504 for a supply of 4 grams, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Stiolto Respimat is available as a brand name drug only, a generic version is not yet available. View generic Stiolto Respimat availability for more details.
Stiolto Respimat prices
Inhalation Aerosol
Quantity | Per unit | Price |
---|---|---|
4 grams | $126.00 | $503.99 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Stiolto Respimat Coupons, Copay Cards and Rebates
Stiolto Respimat offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Stiolto Respimat Savings Card
Eligible commercially insured patients may pay as little as $0 per monthly prescription with a savings of up to $250 per fill; card valid for 12 uses per year; for additional information contact the program at 844-449-4704.
- Applies to:
- Stiolto Respimat
- Number of uses:
- 12 fills per year
- Expires
- December 31, 2023
Form more information phone: 844-449-4704 or Visit website
Stiolto Respimat Mail-Order Pharmacy Rebate
Eligible commercially insured patients using a mail-order pharmacy that does not accept the Savings Card may request a rebate online; for additional information contact the program at 844-449-4704.
- Applies to:
- Stiolto Respimat
- Number of uses:
- One rebate per prescription fill
- Expires
- December 31, 2023
Form more information phone: 866-496-8714 or Visit website
Stiolto Respimat RespiPoints
Eligible patients may register with the program to earn points to redeem digital gift cards; for additional information contact the program at respipoints.support@healthprize.com.
- Applies to:
- Stiolto Respimat
- Number of uses:
- Per length of program
Patient Assistance & Copay Programs for Stiolto Respimat
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: BI Cares Patient Assistance Program
Eligibility requirements:- Must be uninsured or underinsured
- Based on FPL
- Not specified
- Must be residing in the US or US territory
- *Call (800) 556-8317 and, when prompted, choose Option 2 to use the automated refill request system. Or, visit our website at: www.bipatientassistance.com to request your refill online. Some Medicare eligible patients who have difficulty meeting their Part D drug costs and who do not qualify for other assistance may be eligible.
- Stiolto Respimat (tiotropium bromide-olodaterol) Spray; Inhalation
More information please phone: 800-556-8317 Visit Website
More about Stiolto Respimat (olodaterol / tiotropium)
- Check interactions
- Compare alternatives
- Reviews (43)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bronchodilator combinations
- En español